TipRanks
THC Therapeutics Inc (THCT)
OTHER OTC:THCT
US Market

THC Therapeutics (THCT) Income Statement

33 Followers

THC Therapeutics Income Statement

Last quarter (Q3 2024), THC Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, THC Therapeutics's net income was $104.62K. See THC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jul 23Jul 22Jul 21Jul 20Jul 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.39K$ -12.33K$ -16.37K$ -20.11K$ -25.56K
Operating Expenses
$ 493.91K$ 1.75M$ 939.98K$ 1.32M$ 24.26M
Depreciation and Amortization
$ 1.39K$ 12.33K$ 16.37K$ 20.11K$ 25.56K
EBITDA
$ -492.52K$ -1.73M$ -923.61K$ -1.37M$ -24.23M
Operating Income
$ -493.91K$ -1.75M$ -939.98K$ -1.32M$ -26.69M
Other Income/Expenses
$ 106.88K$ 227.10K$ -945.47K$ -540.99K$ 3.38M
Pretax Income
$ -387.04K$ -1.52M$ -1.89M$ -1.93M$ -23.31M
Net Income
$ -387.04K$ -1.52M$ -1.89M$ -1.93M$ -23.61M
Per Share Metrics
Basic EPS
$ -0.01$ -0.05$ -0.08$ -0.15$ -1.77
Diluted EPS
$ -0.01$ -0.05$ -0.08$ -0.15$ -1.77
Weighted Average Shares Outstanding
32.81M 33.24M 23.66M 16.55M 13.38M
Weighted Average Shares Outstanding (Diluted)
32.81M 33.24M 23.66M 16.55M 13.38M
Currency in USD

THC Therapeutics Earnings and Revenue History